Summary
- Current Price
- As of today, ICLR price is $98.41, up +1.98% on
- Current Price All-Time High
- ICLR price is currently -71.70% below its historical high of $347.72 set on
- Market Cap
- ICLR current market cap is $8B, down -50.46% year-over-year
- PE Ratio
- ICLR current PE ratio is 13.30
- Revenue
- ICLR current annual revenue is $8.28B, up +1.99% year-over-year
- Next Earnings
- The next earnings release for ICLR is on
Profile
| Metric | Value |
|---|---|
| Full Name | ICON Public Limited Company |
| Ticker | NASDAQ: ICLR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | Ireland |
| IPO | |
| Indexes | Not included |
| Website | iconplc.com |
| Employees | 39,900 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $98.41 | |
| Price, 1D Change | +1.98% | |
| Market Cap | $8B | |
| - | ||
| PE Ratio | 13.30 | |
| Beta | 1.23 | |
| Revenue | $8B | |
| Revenue, 1Y Change | +1.99% | |
| EPS | $9.53 | |
| EPS, 1Y Change | +28.77% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $9.53 | |
| EPS Estimate | $13.03 | |
| EPS Est. Change | +36.73% | |
| Revenue | $8.28B | |
| Revenue Estimate | $8.07B | |
| Revenue Est. Change | -2.57% | |
| Current Price | $98.41 | |
| Price Target | - | $200.00 |
| Price Tgt. Change | - | +103.23% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.78 | $7.40 | -42.08% | |
| $14.01 | $9.53 | -31.98% | |
| $13.03 | N/A | +36.73% | |
| $12.99 | N/A | +36.26% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $8.15B | $8.12B | -0.31% | |
| $8.28B | $8.28B | +0.01% | |
| $8.07B | N/A | -2.57% | |
| $8.06B | N/A | -2.69% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -48.56% | |
| Price, 3Y | -56.76% | |
| Market Cap, 1Y | -50.46% | |
| Market Cap, 3Y | -58.85% | |
| Revenue, 1Y | +1.99% | |
| Revenue, 3Y | +51.10% | |
| EPS, 1Y | +28.77% | |
| EPS, 3Y | +323.55% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $98.41 | |
| SMA 200 | $164.64 | |
| SMA 200 vs Price | +67.30% | |
| SMA 50 | $170.63 | |
| SMA 50 vs Price | +73.39% | |
| Beta | 1.23 | |
| ATR | $12.11 | |
| 14-Day RSI | 27.78 | |
| 10-Day Volatility | 240.26% | |
| 1-Year Volatility | 66.94% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $8.28B | |
| EPS | $9.53 | |
| Gross Profit | $1.95B | |
| Gross Margin | 23.52% | |
| Operating Profit | $1.22B | |
| Operating Margin | 14.51% | |
| Net Income | $791.47M | |
| Net Margin | 9.56% | |
| EBITDA | $1.56B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.38 | |
| 1.26 | ||
| 1.26 | ||
| - | ||
| 6 | ||
| 1.60 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 13.30 | |
| 0.94 | ||
| 0.82 | ||
| 6.63 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $9.52B | |
| $538.79M | ||
| $16.88B | ||
| $3.53B | ||
| $7.35B | ||
| $2.80B | ||
| Total Debt | $3.60B | |
| $66.55M | ||
| $173.03M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $7.49B | ||
| $746.43M | ||
| $6.33B | ||
| $0.00 | ||
| $528.29M | ||
| $0.00 | ||
| $77.71M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $1.29B | ||
| -$266.79M | ||
| -$837.18M | ||
| Capex | $168.06M | |
| $1.12B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| TD Cowen | → | |
| Truist Securities | → | |
| Barclays | → | |
| BMO Capital | ||
| TD Cowen | → | |
| Barclays | → | |
| Barclays | → | |
| Jefferies | → | |
| Rothschild & Co | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
Screeners with ICLR
FAQ
What is the ticker symbol for ICON Public Limited Company?
The ticker symbol for ICON Public Limited Company is NASDAQ:ICLR
Does ICON Public Limited Company pay dividends?
No, ICON Public Limited Company does not pay dividends
What sector is ICON Public Limited Company in?
ICON Public Limited Company is in the Healthcare sector
What industry is ICON Public Limited Company in?
ICON Public Limited Company is in the Diagnostics & Research industry
What country is ICON Public Limited Company based in?
ICON Public Limited Company is headquartered in Ireland
When did ICON Public Limited Company go public?
ICON Public Limited Company initial public offering (IPO) was on May 15, 1998
Is ICON Public Limited Company in the S&P 500?
No, ICON Public Limited Company is not included in the S&P 500 index
Is ICON Public Limited Company in the NASDAQ 100?
No, ICON Public Limited Company is not included in the NASDAQ 100 index
Is ICON Public Limited Company in the Dow Jones?
No, ICON Public Limited Company is not included in the Dow Jones index
When was ICON Public Limited Company last earnings report?
ICON Public Limited Company's most recent earnings report was on October 22, 2025
When does ICON Public Limited Company report earnings?
The next expected earnings date for ICON Public Limited Company is February 25, 2026
Data Sources & References
- ICLR Official Website www.iconplc.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1060955/000162828025045879/0001628280-25-045879-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1060955/000106095525000016/0001060955-25-000016-index.htm
- ICLR Profile on Yahoo Finance finance.yahoo.com/quote/ICLR
- ICLR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/iclr